Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
Clinical trial NCT05886257 · WITHDRAWN
Trial details
- NCT number
- NCT05886257
- Sponsor
- Shi Ming
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2023-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.